NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

cancer weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of cancer weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Management



Multidisciplinary management of head and neck sarcomas advised



October 25th, 2005

A multidisciplinary approach to management of head and neck sarcomas was advised.

According to recent research from England, "Head and neck sarcomas are extremely rare. This article reviews the management and outcomes in a multidisciplinary clinic."

"The records of 41 male and 19 female patients (mean age, 50 years) were reviewed. Forty percent underwent surgical resection only, 35% underwent surgery and adjuvant therapy, and 25% underwent radiotherapy and/or chemotherapy without surgery. Seventy-one percent had complete histologic clearance. The mean follow-up was 3 years and 10 months, with an overall 5-year survival rate of 60%," explained R.J....


Source: cancer weekly (2005-10-25)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login